Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2019-07-12
4:34 pm
Sale		13DArbutus Biopharma Corporation
ABUS		SVF Investments (UK) Ltd0
0%		-16,013,540decrease
(Position Closed)		View
2019-07-12
4:32 pm
Sale		13DUrovant Sciences Ltd.
UROV		SVF Investments (UK) Ltd0
0%		-22,703,669decrease
(Position Closed)		View
2019-07-12
4:31 pm
Sale		13DMyovant Sciences Ltd.
MYOV		SVF Investments (UK) Ltd0
0%		-40,765,599decrease
(Position Closed)		View
2019-07-12
4:29 pm
Sale		13DSio Gene Therapies Inc.
SIOX		SVF Investments (UK) Ltd0
0%		-105,952,381decrease
(Position Closed)		View
2019-06-05
4:22 pm
Purchase		13DMyovant Sciences Ltd.
MYOV		SVF Investments (UK) Ltd40,765,599
45.56%		2,424,242increase
(+6.32%)		View
2019-03-19
4:58 pm
Purchase		13DSio Gene Therapies Inc.
SIOX		SVF Investments (UK) Ltd105,952,381
58.15%		6,666,667increase
(+6.71%)		View
2018-12-20
07:00 am
Purchase		13DSio Gene Therapies Inc.
SIOX		SVF Investments (UK) Ltd99,285,714
65.2%		10,000,000increase
(+11.20%)		View
2018-10-10
5:09 pm
Purchase		13DUrovant Sciences Ltd.
UROV		SVF Investments (UK) Ltd22,703,669
75.6%		22,703,669increase
(New Position)		View
2018-06-07
08:31 am
Purchase		13DSio Gene Therapies Inc.
SIOX		SVF Investments (UK) Ltd89,285,714
73.1%		14,285,714increase
(+19.05%)		View
2018-04-04
4:51 pm
Purchase		13DMyovant Sciences Ltd.
MYOV		SVF Investments (UK) Ltd38,341,357
62.87%		1,110,015increase
(+2.98%)		View